The distal fallopian tube: a new model for pelvic serous carcinogenesis.
about
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerPatient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentInvestigative pathology: leading the post-genomic revolutionOvarian cancer screening--current status, future directionsSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerMutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.The cell of origin of ovarian epithelial tumoursGenetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialChlamydia trachomatis Genital Infections.Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.Expression signatures of TP53 mutations in serous ovarian cancers.Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Reliable in vitro studies require appropriate ovarian cancer cell linesIdentification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.Inhibitory role of prohibitin in human ovarian epithelial cancer.Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk womenOvarian Cancer Incidence Corrected for Oophorectomy.A Resident's Perspective of Ovarian Cancer.Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.CA125 in ovarian cancerTwo different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthaseXenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents.Ovulation and extra-ovarian origin of ovarian cancerDriver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Proteomics and ovarian cancer: integrating proteomics information into clinical careMullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsDevelopment of a syngeneic mouse model of epithelial ovarian cancer.The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens.Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.Coming into focus: the nonovarian origins of ovarian cancer.A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histologyDerivation and characterization of matched cell lines from primary and recurrent serous ovarian cancerGenetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium
P2860
Q24633316-4057E3E9-F034-43D2-AB54-C459F55F6B6CQ26829125-72B4DC0A-DDE0-485E-951A-6573E4416CA9Q27002945-33538B79-D9B7-4B94-A002-16A775E8A0BDQ27004471-05719C67-1826-4A90-8B65-0653977A3A8FQ27009306-73668A01-B25E-4691-96D4-4984262CCA63Q27028117-975DC9D6-8C8B-4884-85CA-079420072A93Q27333756-D9DA34FB-820E-437C-8694-B6B8FCC437F7Q28302089-510A638B-084C-4E2F-B5A9-E11FF5A06E62Q28742817-7E5893FA-1D49-4738-81D0-2DBDBC3470D7Q30235030-D9DF0887-91FD-4FF9-AEF9-BB1DCB379C6BQ30423597-8D4CF250-A959-4DAF-8ED6-941C5FDE4A16Q30651522-4738B75F-63EE-4806-B45F-9F6020C9B3B3Q31141440-A34F3522-6D52-419C-9356-702DD68EDF99Q33387074-B9A10AD6-ECA5-4E1A-BC34-A604937BD8B5Q33508232-A46CE926-8239-4ACB-A4A0-CA40C083B8ECQ33588196-E3E7CC9E-4915-4BD0-9AA8-6D22A0360FD3Q33645478-B7EA071C-9E96-4665-8650-F3EB861E48B8Q33759421-FFCEC268-005D-4CD1-A1B9-3B5220514BAAQ33775466-D9838918-5EF4-4509-BFE2-A7B1EEA72B21Q33802761-96F5A89D-395D-4416-A119-E78D619D97C2Q33848119-547CD36B-BE16-4ED7-998F-2123CDD9A2E6Q33850454-5FA1423B-C400-45E1-ABE3-8274B7A57A49Q33850471-11C4FC01-0A9F-4EDD-BDF8-AD2CD8B6849BQ33850475-AE892591-8F0E-4CD8-951B-FDDD389B1B1BQ33859857-087E4B9E-4BE2-47E5-9CD6-87B1C95F5EA0Q33865112-2CEFCFAE-90E4-4EB9-9D4C-CE7E451928F3Q33888942-70F765CF-8819-4330-B2AD-3B46220FCBE0Q33994590-CB8D265A-F7F4-4B65-AC18-D822E873FA84Q34063581-F5F53A8A-D7A4-48A6-9E01-59549A8741D4Q34103978-0B69D0AA-AC11-47F9-BA79-3FB110453302Q34126627-C3767F21-C6B2-4FAA-8164-C69AC84CE735Q34279411-B9084421-EC69-4080-BD10-4CCF569B3102Q34282708-FA6742E8-AE52-423C-8537-5B3E140A5CCBQ34288214-DB6D06A4-0E29-44EF-B157-0E010FB97AAAQ34305434-BB5F9793-503F-487E-BABD-430D96C78C19Q34305493-5479E359-65AB-4978-8617-4429CECE1FBDQ34378112-3E20B12C-42C4-4C5E-8240-6AA6B0C32FBAQ34387999-78F85C68-E004-466E-9682-34F6C34B4775Q34397197-3F6CAB0E-6A51-453C-898C-C67C54413EFFQ34453723-AF6CAF42-1EE7-411E-B5A8-1E8B943585B8
P2860
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@ast
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@en
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@nl
type
label
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@ast
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@en
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@nl
prefLabel
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@ast
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@en
The distal fallopian tube: a new model for pelvic serous carcinogenesis.
@nl
P2093
P1476
The distal fallopian tube: a new model for pelvic serous carcinogenesis
@en
P2093
Alexander Miron
Christopher P Crum
David W Kindelberger
Michael Muto
Tan A Ince
Yonghee Lee
P356
10.1097/GCO.0B013E328011A21F
P577
2007-02-01T00:00:00Z